STRO - SUTRO BIOPHARMA, INC.
21.31
1.610 7.555%
Share volume: 198,657
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$19.70
1.61
0.08%
Summary score
10%
Profitability
0%
Dept financing
12%
Liquidity
37%
Performance
13%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.28%
Return on assets
-7.25%
Return on sales
0%
Return on invested capital
-523.85%
Total debt ratio
40.9%
Debt ratio change over timeo
0%
Current Ratio
4.79%
Quick Ratio
0%
Cash Position Ratio
1.21%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.07%
Return on assets
-8.81%
Return on sales
0%
Return on invested capital
-1167.27%
Total debt ratio
36.4%
Debt ratio change over timeo
0%
Current Ratio
4.74%
Quick Ratio
0%
Cash Position Ratio
0.92%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
14.45%
Return on assets
-5.92%
Return on sales
0%
Return on invested capital
-182.01%
Total debt ratio
25.5%
Debt ratio change over time
0%
Current Ratio
7.29%
Quick Ratio
0%
Cash Position Ratio
1.84%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | STRO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -10.28% | 11.55% | 5.76% | 8.53% |
| Return on assets | -7.25% | 3.57% | 4.02% | 5.96% |
| Return on sales | 0% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | -523.85% | 7.99% | 5.61% | 8.26% |
| Profitability | 0% | 87% | 68% | 93% |
| Total debt ratio | 40.9% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 14% | 25% | 47% | 17% |
| Current Ratio | 4.74% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 0.92% | 0.76% | 2.25% | 1% |
| Liquididy | 40% | 51% | 62% | 40% |
| Short-term ratios | STRO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -9.07% | 17.94% | -1.29% | 11.66% |
| Return on assets | -8.81% | 3.67% | 1.51% | 6.9% |
| Return on sales | 0% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | -1167.27% | 7.17% | -0.65% | 10.66% |
| Profitability | 0% | 74% | 14% | 91% |
| Total debt ratio | 36.4% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 11% | 25% | 30% | 41% |
| Current Ratio | 4.74% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 0.92% | 0.76% | 2.25% | 1% |
| Liquididy | 35% | 35% | 65% | 37% |